Skip to content

7-day free trial with a card.

Plans
TheDesperateTrader
Compare

JBIO vs OMER

TheDesperateTrader.com· Side-by-side stock comparison

$JBIO vs $OMER head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.

$15.19
Price
$13.95
-1.9%
Day change
-4.1%
$1.07B
Market cap
$1.08B
—
P/E ratio
—
—
Dividend yield
—
55.7M
Free float
68.9M
99.9%
Institutional
57.08%
930K
Avg volume
1.2M
0.9x
Rel. volume
2.1x
25% of 52w
52-week range
50% of 52w
140
Scanner alerts 30d
118
Pharmaceutical Preparations
Sector
PHARMACEUTICAL PREPARATIONS

JBIO vs OMER: trend, levels and the market

One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.

Even, 2 each
Performance
+22%
1 year
+68%
+13.1%
vs S&P 500
+59.2%
-28.8%
3 months
-28.3%
+0.4%
1 month
-15.1%
Trend
Mixed
Trend
Downtrend
$15.00 above
50-day avg
$17.92 below
$18.21 below
200-day avg
$13.83 at it
Key levels
$16.35 +7.6%
Resistance
$15.27 +9.5%
$14.04 -7.6%
Loading zone
$14.48 +3.8%
$14.81 -2.5%
Support
$10.80 -22.6%
$JBIO$15.19
$OMER$13.95
SupportLoading zoneResistancePrice
  • ·OMER is the weaker of the two on trend, below both its 50- and 200-day averages, while JBIO has held above one of them.
  • ·Both beat the market over the past year: JBIO +22% and OMER +68%, against the S&P 500 at +8.8%.
  • ·The last month has flipped the order: JBIO leads over the month (+0.4% against -15.1%) even though OMER leads over the year.
  • ·JBIO sits closer to its support, 2.5% above it at $14.81, while OMER is 22.6% above its own at $10.80.

Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.

JBIO vs OMER: the quick read

  • ·OMER is the larger company by market cap ($1.08B vs $1.07B).
  • ·JBIO has been more active on our scanner (140 vs 118 alerts in 30 days).
  • ·JBIO has the smaller float (55.7M vs 68.9M), which tends to mean sharper, more volatile moves.
  • ·These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
  • ·Both stay busy on our scanner, 140 and 118 unusual-volume alerts over 30 days, so neither is the quiet one here.
  • ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
  • ·OMER is the one in play today, trading about 2.1x its normal volume, which is what puts a name on our scanner in the first place.

Objective differences only. Not investment advice.

Watching JBIO or OMER? Get each morning’s movers by email

Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Frequently asked questions

Everything you need to know comparing JBIO and OMER on TheDesperateTrader.

Is JBIO or OMER the better stock?
"Better" depends on your goal, and these two are not alike. OMER is the larger company by market cap ($1.08B vs $1.07B). JBIO has been more active on our scanner (140 vs 118 alerts in 30 days). JBIO has the smaller float (55.7M vs 68.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
What is the difference between JBIO and OMER?
The differences that matter: they are not in the same business - JBIO is pharmaceutical preparations and OMER is pharmaceutical preparations; they are similar in size ($1.07B vs $1.08B); they trade at very different share prices ($15.19 vs $13.95); JBIO sits at 25% of its 52-week range against 50% for OMER; our scanner flagged JBIO 140 times in the last 30 days against 118 for OMER. Everything above is measured from the latest completed session and SEC filings.
Which of JBIO and OMER is more active right now?
Right now JBIO is at about 0.9x its normal volume and OMER is at about 2.1x, so OMER is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
Is JBIO or OMER in the stronger trend?
JBIO is above its 50-day average of $15.00 and below its 200-day average of $18.21; OMER is below its 50-day average of $17.92 and below its 200-day average of $13.83. They split the head-to-head evenly, 2 measures each (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
Is this comparison data live?
Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.

Trading JBIO or OMER? Get real-time unusual-volume alerts the moment either one moves, free.

Sign up free
No card · 5 premium days

Same sector, similar size. These are the peers each one is usually weighed against.

Explore the market

Free, live market tools. No account required to look.

Site GuideEvery page explained, and how to trade with itTop Stocks TodaySix ranked stocks, live charts, why each oneRegularsThe names that keep coming back to the top of the scannerDue DiligenceDeep dives on one ticker, traced to SEC filings and the tapeSuper PortfolioEvery big holding from 13F filings and corporate stakesFree Stock ScannersEvery scanner in one placeCaught EarlyWhat our scanner flagged before it ranHow It WorksOur data, methodology & accuracyTrading CalculatorsPosition size, profit & average downTrading Taxes ExplainedWash sales, trader status and what you oweStock Market TodayWhat’s actually moving right nowLow Float MoversWho traded their whole float todayBetting AgainstWho the market is short, and which funds hold putsOur Call RecordEvery name we posted and what it did next, losers includedStocks to WatchTop 10 to watch next session, with reasonsTrending StocksWhat’s moving & being searched nowStock Sectors & ThemesAI, crypto, energy, banks & 40 moreBiggest Gainers TodayTop gainers & most activeWhy Stocks Are MovingToday’s movers + the catalyst behind eachInsider BuyingStocks insiders are buying (Form 4)Biggest Losers TodayTop decliners & worst performersPremarket MoversTop gainers & losers before the bellGap ScannerBiggest gap ups & downs. Did it fill?After Hours MoversTop gainers & losers after the closeMost Active StocksHighest dollar-volume names52-Week Highs & LowsStocks making new highs & lowsStock SplitsUpcoming & recent, and what happened afterOversold StocksLowest RSI, mean-reversion watchLow Float StocksSmallest floats, squeeze watchMost Volatile StocksBiggest daily range by ATR%Most Shorted StocksHighest short % of floatShort Squeeze StocksTop squeeze candidates by scorePenny StocksMost active under $5Stocks Under $1Most active sub-$1 namesStocks Under $10Most active under $10Overbought StocksHighest RSI, extended / pullback watchWeekly MoversBiggest gainers & losers this weekStock ScreenerScan by price, volume & RVOLThe Money MapMarket cap added or wiped, by sectorSector PerformanceBest & worst sectors todayStore ClosuresRetail & restaurant stocks under pressureEarnings CalendarWho reports before open & after closeEarnings Next WeekThe week ahead, biggest names by dayMoving After EarningsBiggest post-earnings gainers & losersEconomic CalendarFOMC, CPI, jobs & market-moving dataDividend CalendarEx-dates, yields & buy-by datesIPO CalendarRecent & upcoming stock listingsDaily RecapHow each session played outRVOL ScannerLive unusual-volume alertsHalt ScannerLive trading halts & resumesStock Halts TodayHalted stocks + reasons & resumesMost-Halted StocksRanked: which stocks halt most, 30dLive AlertsThe real-time scanner feedSmart MoneyInsider buys, 5% stakes & 13FReddit RadarTrending tickers & top postsGoogle Search RadarStocks America is Googling nowMarket CalendarEconomic, earnings & dividends in oneCrypto PricesLive Bitcoin, Ethereum & top coinsCurrency ConverterExchange rates: EUR, GBP, JPY & moreMortgage RatesCurrent 30-year & 15-year ratesAI StocksThe AI buildout: chips, cloud & softwareSemiconductor StocksChipmakers & equipment, and why they move